Immediate Impact
1 by Nobel laureates 3 from Science/Nature 74 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of S. Cohen being referenced
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. Cohen | 145 | 49 | 86 | 50 | 8 | 246 | |
| Viktoriya Pavlych | 151 | 60 | 61 | 22 | 11 | 280 | |
| Stina Lindblad | 174 | 66 | 54 | 76 | 6 | 285 | |
| Ann Igoe | 156 | 108 | 68 | 40 | 7 | 294 | |
| H Seifert | 129 | 33 | 41 | 52 | 6 | 289 | |
| A Van Hoof | 114 | 45 | 62 | 29 | 9 | 216 | |
| Claudio Mastaglio | 136 | 54 | 61 | 72 | 7 | 223 | |
| Emily Sutton | 188 | 93 | 36 | 85 | 13 | 286 | |
| Kaoru Takase-Minegishi | 170 | 55 | 67 | 20 | 11 | 271 | |
| V. Martínez-Taboada | 127 | 108 | 71 | 34 | 11 | 270 | |
| Fabio De Gennaro | 81 | 36 | 42 | 24 | 10 | 159 |
All Works
Loading papers...